Literature DB >> 10712520

Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).

F Depoortere1, I Pirson, J Bartek, J E Dumont, P P Roger.   

Abstract

Dog thyroid epithelial cells in primary culture constitute a physiologically relevant model of positive control of DNA synthesis initiation and G0-S prereplicative phase progression by cAMP as a second messenger for thyrotropin (thyroid-stimulating hormone [TSH]). As previously shown in this system, the cAMP-dependent mitogenic pathway differs from growth factor cascades as it stimulates the accumulation of p27(kip1) but not cyclins D. Nevertheless, TSH induces the nuclear translocations and assembly of cyclin D3 and cdk4, which are essential in cAMP-dependent mitogenesis. Here we demonstrate that transforming growth factor beta(1) (TGFbeta(1)) selectively inhibits the cAMP-dependent cell cycle in mid-G1 and various cell cycle regulatory events, but it weakly affects the stimulation of DNA synthesis by epidermal growth factor (EGF), hepatocyte growth factor, serum, and phorbol esters. EGF+serum and TSH did not interfere importantly with TGFbeta receptor signaling, because they did not affect the TGFbeta-induced nuclear translocation of Smad 2 and 3. TGFbeta inhibited the phosphorylation of Rb, p107, and p130 induced by TSH, but it weakly affected the phosphorylation state of Rb-related proteins in EGF+serum-treated cells. TGFbeta did not inhibit c-myc expression. In TSH-stimulated cells, TGFbeta did not affect the expression of cyclin D3, cdk4, and p27(kip1), nor the induced formation of cyclin D3-cdk4 complexes, but it prevented the TSH-induced relocalization of p27(kip1) from cdk2 to cyclin D3-cdk4. It prevented the nuclear translocations of cdk4 and cyclin D3 without altering the assembly of cyclin D3-cdk4 complexes probably formed in the cytoplasm, where they were prevented from sequestering nuclear p27(kip1) away from cdk2. This study dissociates the assembly of cyclin D3-cdk4 complexes from their nuclear localization and association with p27(kip1). It provides a new mechanism of regulation of proliferation by TGFbeta, which points out the subcellular location of cyclin D-cdk4 complexes as a crucial factor integrating mitogenic and antimitogenic regulations in an epithelial cell in primary culture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712520      PMCID: PMC14831          DOI: 10.1091/mbc.11.3.1061

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  96 in total

1.  Regulation of dog thyroid epithelial cell cycle by forskolin, an adenylate cyclase activator.

Authors:  P P Roger; P Servais; J E Dumont
Journal:  Exp Cell Res       Date:  1987-10       Impact factor: 3.905

2.  TGF-beta inhibits growth factor-induced DNA synthesis in hamster fibroblasts without affecting the early mitogenic events.

Authors:  J C Chambard; J Pouysségur
Journal:  J Cell Physiol       Date:  1988-04       Impact factor: 6.384

3.  In vitro demonstration of a TSH-specific growth desensitising mechanism in rat thyroid epithelium.

Authors:  P Smith; E D Williams; D Wynford-Thomas
Journal:  Mol Cell Endocrinol       Date:  1987-05       Impact factor: 4.102

4.  Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter.

Authors:  B Grubeck-Loebenstein; G Buchan; R Sadeghi; M Kissonerghis; M Londei; M Turner; K Pirich; R Roka; B Niederle; H Kassal
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

5.  Type beta transforming growth factor: a bifunctional regulator of cellular growth.

Authors:  A B Roberts; M A Anzano; L M Wakefield; N S Roche; D F Stern; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  Induction of DNA synthesis in dog thyrocytes in primary culture: synergistic effects of thyrotropin and cyclic AMP with epidermal growth factor and insulin.

Authors:  P P Roger; P Servais; J E Dumont
Journal:  J Cell Physiol       Date:  1987-01       Impact factor: 6.384

7.  Effects of transforming growth factor-beta on deoxyribonucleic acid synthesis and iodine metabolism in porcine thyroid cells in culture.

Authors:  T Tsushima; M Arai; M Saji; Y Ohba; H Murakami; E Ohmura; K Sato; K Shizume
Journal:  Endocrinology       Date:  1988-08       Impact factor: 4.736

8.  Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.

Authors:  J Vlach; S Hennecke; K Alevizopoulos; D Conti; B Amati
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

9.  Cyclin D3 accumulation and activity integrate and rank the comitogenic pathways of thyrotropin and insulin in thyrocytes in primary culture.

Authors:  A Van Keymeulen; J Bartek; J E Dumont; P P Roger
Journal:  Oncogene       Date:  1999-12-02       Impact factor: 9.867

10.  Control of growth in the rat thyroid--an example of specific desensitization to trophic hormone stimulation.

Authors:  D Wynford-Thomas; B M Stringer; H R Harach; E D Williams
Journal:  Experientia       Date:  1983-04-15
View more
  16 in total

1.  Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation.

Authors:  Ana Sofia Rocha; Sabine Paternot; Katia Coulonval; Jacques E Dumont; Paula Soares; Pierre P Roger
Journal:  Mol Biol Cell       Date:  2008-09-17       Impact factor: 4.138

Review 2.  Molecular pathogenesis of nodular goiter.

Authors:  Ralf Paschke
Journal:  Langenbecks Arch Surg       Date:  2011-04-14       Impact factor: 3.445

3.  Stimulation of cAMP signalling allows isolation of clonal pancreatic precursor cells from adult mouse pancreas.

Authors:  T Yamamoto; E Yamato; H Taniguchi; M Shimoda; F Tashiro; M Hosoi; T Sato; S Fujii; J-I Miyazaki
Journal:  Diabetologia       Date:  2006-08-08       Impact factor: 10.122

4.  cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4.

Authors:  Sara Blancquaert; Lifu Wang; Sabine Paternot; Katia Coulonval; Jacques E Dumont; Thurl E Harris; Pierre P Roger
Journal:  Mol Endocrinol       Date:  2010-05-19

5.  Inhibitory RNA molecules in immunotherapy for cancer.

Authors:  Chih-Ping Mao; T-C Wu
Journal:  Methods Mol Biol       Date:  2010

6.  Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors".

Authors:  Laurence Bockstaele; Hugues Kooken; Frederick Libert; Sabine Paternot; Jacques E Dumont; Yvan de Launoit; Pierre P Roger; Katia Coulonval
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

7.  Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation.

Authors:  Laurence Bockstaele; Xavier Bisteau; Sabine Paternot; Pierre P Roger
Journal:  Mol Cell Biol       Date:  2009-06-01       Impact factor: 4.272

8.  A novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95.

Authors:  Tatjana Arsenijevic; Chantal Degraef; Jacques E Dumont; Pierre P Roger; Isabelle Pirson
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

9.  Acceleration of BRAFV600E-induced thyroid carcinogenesis by TGFβ signal deficiency in mice.

Authors:  Mika Shimamura; Tomomi Kurashige; Rassul Kuatov; Masahiro Nakashima; Yuji Nagayama
Journal:  Endocrine       Date:  2020-04-12       Impact factor: 3.633

10.  Effects of the Smad4 C324Y mutation on thyroid cell proliferation.

Authors:  Sonia D'Inzeo; Arianna Nicolussi; Francesco Nardi; Anna Coppa
Journal:  Int J Oncol       Date:  2013-04-17       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.